JGD - you and others are good at this - Just do the quick financial math on the 200,000 RecoveryRx devices, to be included in surgical kits in May. Your speculation model can be instantly modified with different selling prices to Braun, hospitals, day surgery clinics, etc.
BIEL sells to B. Braun for for inclusion with Braun devices, prosthesis, screws, plates and other hardware and sale of the whole to UK hospitals for use in surgical procedures. Seems to me this is an established schedule for initiating the RecoveryRx roll-out with Braun. Assume BIEL will also sell to another distributor who willing turn sell to the other surgical unit players in the UK.
Either the Braun and eventually all RecoveryRx devices will, or will not, be covered under the NHS (National Health Service) tariff. If an affirmative decision by NHS on the B. Braun application for such coverage comes down prior to the Braun combo roll-out, RecoveryRx costs will be covered by NHS. If not, the hospitals will have to either absorb the costs, or pass them on to patients, or their insurers.
My sense is someone knows the timing of the NHS addition to the tariff initially for Braun, giving us a good inkling, because the inventory pipeline of orthopaedic devices, with RecoveryRx included in the sterile combo unit, must be adequately filled in advance. Eventually, hospitals may stock hundreds of RecoveryRx devices under their own inventory sku for use in surgical procedures where Braun devices are not used. Easy to see how someone very bright at Braun understood the vision, thereby making Braun first out of the surgical starting blocks in the UK. It is not outlandish to speculate that the recent distributor addition in the UK is for the filling of the non-Braun devices surgical pipeline??? Tsunami, quiet, steady build . . . .
